Wilms' tumor and neuroblastoma
Morgenstern, BZ, Krivoshik, AP, Rodriguez, V, Anderson, PM
Published in Acta Paediatrica (01.04.2004)
Published in Acta Paediatrica (01.04.2004)
Get full text
Journal Article
Ongoing phase I studies of ABT-263: Mitigating Bcl-X L induced thrombocytopenia with lead-in and continuous dosing
Roberts, A. W., Wilson, W., Gandhi, L., O'Connor, O. A., Rudin, C. M., Brown, J. R., Xiong, H., Chiu, Y., Enschede, S., Krivoshik, A. P.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
A phase 1 study evaluating the safety, pharmacokinetics, and efficacy of ABT-263 in subjects with refractory or relapsed lymphoid malignancies
Wilson, W. H., Czuczman, M. S., LaCasce, A. S., Gerecitano, J. F., Leonard, J. P., Dunleavy, K., Krivoshik, A. P., Xiong, H., Chiu, Y., O’Connor, O. A.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Reduction in platelet counts as a mechanistic biomarker and guide for adaptive dose-escalation in phase I studies of the Bcl-2 family inhibitor ABT-263
Roberts, A., Gandhi, L., O'Connor, O. A., Rudin, C. M., Khaira, D., Xiong, H., Chiu, Y., Greco, R., Krivoshik, A. P., Wilson, W. H.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
The pharmacokinetics (PK) and pharmacodynamics (PD) of ABT-751 in children with recurrent neuroblastoma or other solid tumors
Fox, E., Widemann, B. C., Maris, J. M., Cohn, S. L., Xiong, H., Krivoshik, A. P., Hagey, A. E., Adamson, P. C., Balis, F. M.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article